Trial Profile
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2013
Price :
$35
*
At a glance
- Drugs Spheramine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms STEPS
- 21 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 21 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 21 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.